Prospective, randomized, double-blind, placebo-controlled trial of ulinastatin for prevention of hyperenzymemia after double balloon endoscopy via the antegrade approach

Digestive Endoscopy

Volumn 25, Issue 4, 2013, Pages 421-427

  Itaba, Soichi ^a   Nakamura, Kazuhiko ^a   Aso, Akira ^a   Tokunaga, Shoji ^a   Akiho, Hirotada ^a   Ihara, Eikichi ^a   Iboshi, Yoichiro ^a   Iwasa, Tsutomu ^a   Akahoshi, Kazuya ^a   Ito, Tetsuhide ^a   Takayanagi, Ryoichi ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

double balloon endoscopy; hyperamylasemia; hyperenzymemia; hyperlipasemia; pancreatitis

Indexed keywords

ALPHA AMYLASE PANCREAS ISOENZYME; ISOAMYLASE; MIDAZOLAM; PENTAZOCINE; PLACEBO; TRIACYLGLYCEROL LIPASE; ULINASTATIN;

ACUTE PANCREATITIS; ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BALLOON ENTEROSCOPY; DOUBLE BLIND PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME DEFECT; FEMALE; HUMAN; HYPERAMYLASEMIA; HYPERENZYMEMIA; MALE; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; STOMACH PROTECTION; TREATMENT DURATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

DOUBLE BALLOON ENDOSCOPY; HYPERAMYLASEMIA; HYPERENZYMEMIA; HYPERLIPASEMIA; PANCREATITIS;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BALLOON ENTEROSCOPY; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; LIPASE; MALE; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRYPSIN INHIBITORS; YOUNG ADULT;

EID: 84879696307     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/den.12014     Document Type: Article

References (33)

1. Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a non-surgical steerable double-balloon method. Gastrointest. Endosc. 2001; 53: 216-220.
2. Yamamoto H, Yano T, Kita H, Sunada K, Ido K, Sugano K,. New system of double-balloon enteroscopy for diagnosis and treatment of small intestinal disorders. Gastroenterology 2003; 125: 1556-1557.
3. Mensink PB, Haringsma J, Kucharzik T, et al. Complications of double balloon enteroscopy: a multicenter survey. Endoscopy 2007; 39: 613-615.
4. Honda K, Itaba S, Mizutani T, et al. An increase in the serum amylase level in patients after peroral double-balloon enteroscopy: an association with the development of pancreatitis. Endoscopy 2006; 38: 1040-1043.
5. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N. Engl. J. Med. 1996; 335: 909-918.
6. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest. Endosc. 1998; 48: 1-10.
7. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am. J. Gastroenterol. 2001; 96: 417-423.
8. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post ERCP pancreatitis: a prospective multicenter study. Gastrointest. Endosc. 2001; 54: 425-434.
9. Andriulli A, Solmi L, Loperfido S, et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin. Gastroenterol. Hepatol. 2004; 2: 713-718.
10. Beauchant M, Ingrand P, Favriel JM, et al. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. Endoscopy 2008; 40: 631-636.
11. Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of rectal NSAIDs in the prevention of post ERCP pancreatitis. Gut 2008; 57: 1262-1267.
12. Choi CW, Kang DH, Kim GH, et al. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Gastrointest. Endosc. 2009; 69: 11-18.
13. Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin. Gastroenterol. Hepatol. 2005; 3: 376-383.
14. Ohnishi H, Kosuzume H, Ashida Y, Kato K, Honjo I,. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig. Dis. Sci. 1984; 29: 26-32.
15. Pelletier G, Nee N, Brivet M, Etienne JP, Lemonnier A,. Upper gastrointestinal endoscopy; an unrecognized cause of hyperamylasemia. Dig. Dis. Sci. 1987; 32: 254-256.
16. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest. Endosc. 1991; 37: 383-393.
17. Kaffes AJ, Siah C, Koo JH,. Clinical outcomes after double-balloon enteroscopy in patients with obscure GI bleeding and a prospective capsule endoscopy. Gastrointest. Endosc. 2007; 66: 304-309.
18. Möschler O, May A, Müller MK, Ell C, German DBE Study Group. Complications in and performance of double-balloon enteroscopy (DBE): results from a large prospective DBE database in Germany. Endoscopy 2011; 43: 484-489.
19. Heine GDN, Hadithi M, Groenen MJM, Kuipers EJ, Jacobs MA, Mulder CJ,. Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy 2006; 38: 42-48.
20. Kopácová M, Rejchrt S, Tachecí I, Bures J,. Hyperamylasemia of uncertain significance associated with oral double balloon enteroscopy. Gastrointest. Endosc. 2007; 66: 1133-1138.
21. Tanaka S, Mitsui K, Tatsuguchi A, et al. Current status of double balloon endoscopy-indications, insertion route, sedation, complications, technical matters. Gastrointest. Endosc. 2007; 66: S30-33.
22. Jarbandhan SV, van Weyenberg SJ, van der Veer WM, Heine DJ, Mulder CJ, Jacobs MA,. Double balloon endoscopy associated pancreatitis: A description of six cases. World J. Gastroenterol. 2008; 14: 720-724.
23. Aktas H, Mensink PB, Hairngsma J, Kuipers EJ,. Low incidence of hyperamylasemia after proximal double-balloon enteroscopy: has the insertion technique improved? Endoscopy 2009; 41: 670-673.
24. May A, Färber MA, Aschmoneit I, et al. Prospective multicenter trial comparing push-and-pull enteroscopy with the single- and double-balloon techniques in patients with small-bowel disorders. Am. J. Gastroenterol. 2010; 105: 575-581.
25. Pata C, Akyüz U, Erzin Y, Multlu N, Mercan A, Dirican A,. Post-procedure elevated amylase and lipase levels after double-balloon enteroscopy: relations with the double balloon technique. Dig. Dis. Sci. 2010; 55: 1982-1988.
26. Zepeda-Gõmez S, Barreto-Zuniga R, Ponce-de-Leõn S, et al. Risk of hyperamylasemia and acute pancreatitis after double-balloon enteroscopy: a prospective study. Endoscopy 2011; 43: 766-770.
27. Groenen MJ, Moreels TG, Orlent H, Haringsma J, Kuipers EJ,. Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool. Endoscopy 2006; 38: 82-85.
28. Honda K, Mizutani T, Nakamura K, et al. Acute pancreatitis associated with peroral double-balloon enteroscopy: A case report. World J. Gastroenterol. 2006; 12: 1802-1804.
29. Matsushita M, Shimatani M, Uchida K, Okazaki K,. Mechanism of acute pancreatitis after peroral double balloon enteroscopy. Endoscopy 2007; 39: 480.
30. Honda K, Nakamura K, Itaba S, Akiho H, Arita Y, Takayanagi R,. Reply to M. Matsushita et al. Endoscopy 2007; 39: 481.
31. LaFerla G, Gordon S, Archibald M, Murray WR,. Hyperamylasemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography. Pancreas 1986; 1: 160-163.
32. Gottlieb K, Sherman S, Pezzi J, Esber E, Lehman GA,. Early recognition of post-ERCP pancreatitis by initial assessment and serum pancreatic enzymes. Am. J. Gastroenterol. 1996; 91: 1553-1557.
33. Thomas PR, Sengupta S,. Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4-h post procedure amylase level. J. Gastroenterol. Hepatol. 2001; 16: 923-926.